Dr. Raphael A. Lizcano III, M.D.
Hematology & Oncology (Hematology & Oncology Physician)
1 Medical Center Dr, Dhmc Department Of Medicine
Lebanon, NH 03756
- Medicare participating
At a glance
- Medical school
- Geisel School of Medicine at Dartmouth (2013)
- Years since graduation
- 13
- In the NPI registry since
- 2013
- Medicare patients seen, 2024
- 174
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2013Medical school: Geisel School of Medicine at Dartmouth
- 2013Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
NH license 17634 -
Internal Medicine Physician
MA license 274396 · NH license 17634
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mary Hitchcock Memorial Hospital Lebanon, NH
- Cheshire Medical Center Keene, NH
- Alice Peck Day Memorial Hospital Lebanon, NH
- New London Hospital New London, NH
- Gifford Medical Center Randolph, VT
Medical groups
- Dartmouth-Hitchcock Clinic (1,472 clinicians)
- Mary Hitchcock Memorial Hospital (1,280 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 174
- Services billed
- 502
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 114 | 30 |
| Established patient office or other outpatient visit, 40-54 minutes | 86 | 37 |
| Established patient office or other outpatient visit, 30-39 minutes | 43 | 31 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 24 | 23 |
| Hospital discharge day management, 30 minutes or less | 17 | 15 |
| New patient office or other outpatient visit, 60-74 minutes | 16 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Acyclovir Other prescribers in Lebanon, NH | 41 |
| Hydroxyurea Other prescribers in Lebanon, NH | 20 |
| Posaconazole | 15 |
| Prednisone Other prescribers in Lebanon, NH | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $79.53 in total to this clinician.
| Incyte Corporation | $79.53 |
|---|
| Food and Beverage | $79.53 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $38,480 in research payments for these studies, mostly to the institutions running them.
- A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Sumitomo Pharma America, Inc. · Recruiting · NCT04988555
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.